NDABUCCAL, SUBLINGUALTABLET
Approved
Sep 2006
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
4
Data completeness
5/8 — Partial
FENTORA (fentanyl citrate) by Teva is analgesia. First approved in 2006.
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FENTORA is a buccal/sublingual fentanyl citrate tablet approved in 2006 for rapid-onset pain relief in opioid-tolerant patients. It delivers potent analgesia through transmucosal absorption, bypassing first-pass metabolism for faster onset than oral formulations. The drug works as a mu-opioid receptor agonist to block pain signal transmission.
$0.001BPart D
LOE ApproachingDeclining
1.6 years to LOEMinimal commercial momentum with 46 Part D claims and <$1M spending signals a maturing, contracted franchise with limited team expansion opportunity.
Mechanism of Action
analgesia.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
Started Jul 2011
600 enrolled
CancerPain
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Started Aug 2006
120 enrolled
Pain
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
Started Sep 2005
120 enrolled
Chronic Neuropathic Pain
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
Started Sep 2005
Chronic Low Back Pain
Why This Matters for Your Career
Worked on FENTORA at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.